The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Bone metastasis in prostate cancer: emerging therapeutic strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 1×
“This heterotypic cell–cell interaction induces the fusion of preosteoclasts and the formation of mature multinucleated osteoclasts, which are capable of bone resorption ( Figure 1 )”
BackgroundDocetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Petrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Day, T. F., Guo, X., Garrett-Beal, L., & Yang, Y. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.03.016 · Cited by 1,616
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
TGFβ signalling: a complex web in cancer progression
Ikushima, H., & Miyazono, K. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2853 · Cited by 1,173
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
Berthold, D. R., Pond, G. R., Soban, F., de Wit, R., Eisenberger, M., & Tannock, I. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4008 · Cited by 1,145
Canonical Wnt/β-Catenin Signaling Prevents Osteoblasts from Differentiating into Chondrocytes
Hill, T. P., Später, D., Taketo, M. M., Birchmeier, W., & Hartmann, C. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.013 · Cited by 1,084
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Regulation of cell signalling by uPAR
Smith, H. W., & Marshall, C. J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2821 · Cited by 960
Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J. D., Schu, P., & von Figura, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13453 · Cited by 913
Transforming Growth Factor-β1 to the Bone
Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710
Migliaccio, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5406 · Cited by 672
The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases
Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F. H., McQueney, M. S., Foged, N. T., Delmas, P. D., & Delaissé, J.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32347 · Cited by 644
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 568
Brown, J. E., Cook, R. J., Major, P., Lipton, A., Saad, F., Smith, M., Lee, K.-A., Zheng, M., Hei, Y.-J., & Coleman, R. E. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji002 · Cited by 559
Fizazi, K., Lipton, A., Mariette, X., Body, J.-J., Rahim, Y., Gralow, J. R., Gao, G., Wu, L., Sohn, W., & Jun, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2146 · Cited by 533
Coleman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W. L., & Massagué, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506517102 · Cited by 532
Alliston, T., Choy, L., Ducy, P., Karsenty, G., & Derynck, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2254 · Cited by 526
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Honore, P., Luger, N. M., Sabino, M. A. C., Schwei, M. J., Rogers, S. D., Mach, D. B., O'keefe, P. F., Ramnaraine, M. L., Clohisy, D. R., & Mantyh, P. W. (2000) · Nature Medicine · doi:10.1038/74999 · Cited by 498
Tu, S.-M., Millikan, R. E., Mengistu, B., Delpassand, E. S., Amato, R. J., Pagliaro, L. C., Daliani, D., Papandreou, C. N., Smith, T. L., Kim, J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03639-4 · Cited by 396
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., Vargo-Gogola, T. C., Begtrup, J. L., Peterson, T. E., Fingleton, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.013 · Cited by 393
Seals, D. F., Azucena, E. F., Pass, I., Tesfay, L., Gordon, R., Woodrow, M., Resau, J. H., & Courtneidge, S. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.006 · Cited by 384
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Carducci, M. A., Padley, R. J., Breul, J., Vogelzang, N. J., Zonnenberg, B. A., Daliani, D. D., Schulman, C. C., Nabulsi, A. A., Humerickhouse, R. A., Weinberg, M. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.176 · Cited by 371
Drug resistance in metastatic castration-resistant prostate cancer
Seruga, B., Ocana, A., & Tannock, I. F. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.136 · Cited by 336
Prostate Cancer Cells Promote Osteoblastic Bone Metastases through Wnts
Hall, C. L., Bafico, A., Dai, J., Aaronson, S. A., & Keller, E. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1317 · Cited by 303
Carducci, M. A., Saad, F., Abrahamsson, P., Dearnaley, D. P., Schulman, C. C., North, S. A., Sleep, D. J., Isaacson, J. D., Nelson, J. B., & for the Atrasentan Phase III Study Group Institutions. (2007) · Cancer · doi:10.1002/cncr.22996 · Cited by 294
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
Marzia, M., Sims, N. A., Voit, S., Migliaccio, S., Taranta, A., Bernardini, S., Faraggiana, T., Yoneda, T., Mundy, G. R., Boyce, B. F., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.311 · Cited by 284
Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
Bennett, C. N., Ouyang, H., Ma, Y. L., Zeng, Q., Gerin, I., Sousa, K. M., Lane, T. F., Krishnan, V., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070810 · Cited by 281
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Bellido, T., & Plotkin, L. I. (2011) · Bone · doi:10.1016/j.bone.2010.08.008 · Cited by 265
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
Collins, C., Eary, J. F., Donaldson, G. W., Vernon, C. B., Bush, N. E., Petersdorf, S. H., Livingston, R. B., Gordon, E. E., Chapman, C. R., & Appelbaum, F. R. (1993) · PubMed · Cited by 254
Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606656200 · Cited by 236
Nam, J.-S., Terabe, M., Mamura, M., Kang, M.-J., Chae, H., Stuelten, C., Kohn, E., Tang, B., Sabzevari, H., Anver, M. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0215 · Cited by 233
Role of endothelin-1 in osteoblastic bone metastases
Guise, T. A., Yin, J. J., & Mohammad, K. S. (2003) · Cancer · doi:10.1002/cncr.11129 · Cited by 228
Corey, E., Brown, L. G., Quinn, J. E., Poot, M., Roudier, M. P., Higano, C. S., & Vessella, R. L. (2003) · PubMed · Cited by 227
ten Dijke, P., Krause, C., de Gorter, D. J. J., Löwik, C. W. G. M., & van Bezooijen, R. L. (2008) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.g.01183 · Cited by 224
Huijbers, I. J., Iravani, M., Popov, S., Robertson, D., Al-Sarraj, S., Jones, C., & Isacke, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009808 · Cited by 223
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Mohammad, K. S., Javelaud, D., Fournier, P. G. J., Niewolna, M., McKenna, C. R., Peng, X. H., Duong, V., Dunn, L. K., Mauviel, A., & Guise, T. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2651 · Cited by 221
Korpal, M., Yan, J., Lu, X., Xu, S., Lerit, D. A., & Kang, Y. (2009) · Nature Medicine · doi:10.1038/nm.1943 · Cited by 217
Cathepsin K inhibitors for osteoporosis and potential off-target effects
Brömme, D., & Lecaille, F. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902832661 · Cited by 216
Shariat, S. F., Roehrborn, C. G., McConnell, J. D., Park, S., Alam, N., Wheeler, T. M., & Slawin, K. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6853 · Cited by 209
Dearnaley, D. P., Mason, M. D., Parmar, M. K., Sanders, K., & Sydes, M. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70201-3 · Cited by 204
A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden
Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3940 · Cited by 204
Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
J. Roelofs, A., Thompson, K., H. Ebetino, F., J. Rogers, M., & P. Coxon, F. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793563635 · Cited by 202
Slack, J. K., Adams, R. B., Rovin, J. D., Bissonette, E. A., Stoker, C. E., & Parsons, J. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204208 · Cited by 198
Mohammad, K. S., Chen, C. G., Balooch, G., Stebbins, E., McKenna, C. R., Davis, H., Niewolna, M., Peng, X. H., Nguyen, D. H. N., Ionova-Martin, S. S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005275 · Cited by 179
Rabbani, S. A., Desjardins, J., Bell, A. W., Banville, D., Mazar, A., Henkin, J., & Goltzman, D. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80893-9 · Cited by 174
Fizazi, K., Beuzeboc, P., Lumbroso, J., Haddad, V., Massard, C., Gross-Goupil, M., Di Palma, M., Escudier, B., Theodore, C., Loriot, Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9811 · Cited by 173
Dai, J., Hall, C. L., Escara-Wilke, J. F., Mizokami, A., Keller, J. M., & Keller, E. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6541 · Cited by 169
Ganapathy, V., Ge, R., Grazioli, A., Xie, W., Banach-Petrosky, W., Kang, Y., Lonning, S., McPherson, J., Yingling, J. M., Biswas, S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-122 · Cited by 168
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression
Brubaker, K., Vessella, R., True, L., Thomas, R., & Corey, E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.222 · Cited by 162
Berdeaux, R., Díaz, B., Kim, L., & Martin, G. S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312168 · Cited by 159
Jensen, A. B., Wynne, C. J., Ramírez, G., He, W., Song, Y., Berd, Y., Wang, H., Mehta, A., & Lombardi, A. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.059 · Cited by 158
TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling
Qiu, T., Wu, X., Zhang, F., Clemens, T. L., Wan, M., & Cao, X. (2010) · Nature Cell Biology · doi:10.1038/ncb2022 · Cited by 157
Rho GTPases in osteoclasts: Orchestrators of podosome arrangement
Ory, S., Brazier, H., Pawlak, G., & Blangy, A. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.03.002 · Cited by 154
Sydes, M. R., Parmar, M., James, N. D., Clarke, N. W., Dearnaley, D. P., Mason, M. D., Morgan, R. C., Sanders, K., & Royston, P. J. (2009) · Trials · doi:10.1186/1745-6215-10-39 · Cited by 150
Molecular mechanisms and treatment of bone metastasis
Clines, G. A., & Guise, T. A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000616 · Cited by 145
Vesicular trafficking in osteoclasts
Coxon, F. P., & Taylor, A. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.08.004 · Cited by 133
Xia, W., Unger, P., Miller, L., Nelson, J. B., & Gelman, I. H. (2001) · PubMed · Cited by 128
Synthesis and secretion of collagen by cells of connective tissue, bone, and dentin
Leblond, C. P. (1989) · The Anatomical Record · doi:10.1002/ar.1092240204 · Cited by 126
Tu, C., Ortega-Cava, C. F., Chen, G., Fernandes, N. D., Cavallo‐Medved, D., Sloane, B. F., Band, V., & Band, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5127 · Cited by 123
Body, J., Lipton, A., Gralow, J. R., Steger, G. G., Gao, G., Yeh, H., & Fizazi, K. S. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090810 · Cited by 123
Janjan, N. A., Lutz, S., Bedwinek, J. M., Hartsell, W. F., Ng, A. K., Pieters, R. S., Ratanatharathorn, V., Silberstein, E. B., Taub, R. J., Yasko, A. W., et al. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.9633 · Cited by 122
James, N. D., Caty, A., Payne, H. A., Borre, M., Zonnenberg, B. A., Beuzeboc, P., McIntosh, S., Morris, T., Phung, D., & Dawson, N. A. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09638.x · Cited by 121
Drug-induced morphea: Report of a case induced by balicatib and review of the literature
Peroni, A., Zini, A., Braga, V., Colato, C., Adami, S., & Girolomoni, G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.03.009 · Cited by 113
Fizazi, K. S., Bosserman, L. D., Gao, G., Skácel, T., & Markus, R. A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.022 · Cited by 110
Atley, L. M., Mort, J. S., Lalumière, M., & Eyre, D. R. (2000) · Bone · doi:10.1016/s8756-3282(99)00270-7 · Cited by 108
Schwaninger, R., Rentsch, C. A., Wetterwald, A., van der Horst, G., van Bezooijen, R. L., van der Pluijm, G., Löwik, C. W. G. M., Ackermann, K., Pyerin, W. G., Hamdy, F. C., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.051276 · Cited by 107
James, N. D., Sydes, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Anderson, J., Popert, R., Sanders, K., Morgan, R. C., Stansfeld, J., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08034.x · Cited by 106
Fasquelle, C., Sartelet, A., Li, W., Dive, M., Tamma, N., Michaux, C., Druet, T., Huijbers, I. J., Isacke, C. M., Coppieters, W. R., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000666 · Cited by 102
Asim, M., Siddiqui, I. A., Hafeez, B. B., Baniahmad, A., & Mukhtar, H. (2008) · Oncogene · doi:10.1038/sj.onc.1211016 · Cited by 101
Morris, M. J., Pandit-Taskar, N. D., Carrasquillo, J. A., Divgi, C. R., Slovin, S. F., Kelly, W. K., Rathkopf, D. E., Gignac, G. A., Solit, D. B., Schwartz, L. H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4164 · Cited by 101
Characterization of a Novel Member of the Macrophage Mannose Receptor Type C Lectin Family
Wu, K., Yuan, J. Q., & Lasky, L. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21323 · Cited by 98
Bone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis
Podgorski, I., Linebaugh, B. E., Koblinski, J. E., Rudy, D., Herroon, M. K., Olive, M. B., & Sloane, B. F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080906 · Cited by 95
Fizazi, K. S., Bosserman, L. D., Gao, G., Skácel, T., & Markus, R. A. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.04.023 · Cited by 95
Wienke, D., Davies, G., Johnson, D. A., Sturge, J., Lambros, M. B. K., Savage, K., Elsheikh, S. E., Green, A. R., Ellis, I. O., Robertson, D. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3496 · Cited by 94
Self-citationKoreckij, T. D., Nguyen, H. M., Brown, L. G., Yu, E. Y., Vessella, R. L., & Corey, E. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605178 · Cited by 92
The role of Wnts in bone metastases
Hall, C. L., & Keller, E. T. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9022-2 · Cited by 91
Complementary Roles of Intracellular and Pericellular Collagen Degradation Pathways In Vivo
Wagenaar-Miller, R. A., Engelholm, L. H., Gavard, J., Yamada, S. S., Gutkind, J. S., Behrendt, N., Bugge, T. H., & Holmbeck, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00291-07 · Cited by 91
Sturge, J., Wienke, D., & Isacke, C. M. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200602125 · Cited by 85
Self-citationGreenspan, S. L., Nelson, J. B., Trump, D. L., Wagner, J. M., Miller, M. E., Perera, S., & Resnick, N. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1233 · Cited by 85
Boufker, H. I., Lagneaux, L., Najar, M., Piccart, M. J., Ghanem, G., Body, J., & Journé, F. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-298 · Cited by 81
Lee, Y.-C., Huang, C.-F., Murshed, M., Chu, K., Araujo, J. C., Ye, X., deCrombrugghe, B., Yu-Lee, L.-Y., Gallick, G. E., & Lin, S.-H. (2010) · Oncogene · doi:10.1038/onc.2010.73 · Cited by 79
GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis
Sturge, J., Wienke, D., East, L., Jones, G. E., & Isacke, C. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302124 · Cited by 75
Self-citationEarly Androgen Deprivation for Prostate Cancer?
Eisenberger, M. A., & Walsh, P. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412409 · Cited by 74
Heckel, T., Czupalla, C., Santo, A. I. E., Anitei, M., Sanchez-Fernandez, M. A., Mosch, K., Krause, E., & Hoflack, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804464106 · Cited by 71
Rabbani, S. A., Valentino, M.-L., Arakelian, A., Ali, S., & Boschelli, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0962 · Cited by 69
Rohde, M., & Mayer, H. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9013-5 · Cited by 63
Mandal, S., Johnson, K. R., & Wheelock, M. J. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.09.013 · Cited by 62
Yang, J. C., Bai, L., Yap, S. A., Gao, A. C., Kung, H.-J., & Evans, C. P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1058 · Cited by 61
James, N. D., Sydes, M. R., Clarke, N. W., Mason, M., Dearnaley, D. P., Anderson, J., Popert, R., Sanders, K., Morgan, R. C., Stansfeld, J., et al. (2008) · Clinical Oncology · doi:10.1016/j.clon.2008.07.002 · Cited by 58
Management of Vertebral Metastases in Prostate Cancer: A Retrospective Analysis in 119 Patients
Cereceda, L. E., Fléchon, A., & Droz, J. (2003) · Clinical Prostate Cancer · doi:10.3816/cgc.2003.n.010 · Cited by 56
ERK5 promotes Src-induced podosome formation by limiting Rho activation
Schramp, M., Ying, O., Kim, T. Y., & Martin, G. S. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801078 · Cited by 56
Koutsilieris, M., Sourla, A., Pelletier, G., & Doillon, C. J. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091120 · Cited by 54
Hu, Z., Zhang, Z., Guise, T. A., & Seth, P. K. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.018 · Cited by 49
Evolving Role of Bone Biomarkers in Castration-Resistant Prostate Cancer
Brown, J. E., & Sim, S. (2010) · Neoplasia · doi:10.1593/neo.10610 · Cited by 48
Criswell, T. L., Dumont, N., Barnett, J. V., & Arteaga, C. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6777 · Cited by 47
Endo180 Binds to the C-terminal Region of Type I Collagen
Thomas, E. K., Nakamura, M., Wienke, D., Isacke, C. M., Pozzi, A., & Liang, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501155200 · Cited by 43
Michaelson, M. D., Kaufman, D. S., Kantoff, P. W., Oh, W. K., & Smith, M. R. (2006) · Cancer · doi:10.1002/cncr.22043 · Cited by 41
Kogianni, G., Walker, M. M., Waxman, J., & Sturge, J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.023 · Cited by 39
Self-citationFritz, V., Noël, D., Bouquet, C., Opolon, P., Voide, R., Apparailly, F., Louis‐Plence, P., Bouffi, C., Drissi, H., Xie, C. L., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0139 · Cited by 38
Ishizaka, K., Machida, T., Kobayashi, S., Kanbe, N., Kitahara, S., & Yoshida, K. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01911.x · Cited by 37
Hikita, A., Kadono, Y., Chikuda, H., Fukuda, A., Wakeyama, H., Yasuda, H., Nakamura, K., Oda, H., Miyazaki, T., & Tanaka, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507000200 · Cited by 32
Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan
Drake, J. M., Danke, J. R., & Henry, M. D. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.8.11112 · Cited by 31
Izumi, K., Mizokami, A., Sugimoto, K., Narimoto, K., Miwa, S., Maeda, Y., Kadono, Y., Takashima, M., Koh, E., & Namiki, M. (2009) · Urology · doi:10.1016/j.urology.2009.01.046 · Cited by 31
Hu, Z., Robbins, J. S., Pister, A., Zafar, M. B., Zhang, Z., Gupta, J., Lee, K. J., Neuman, K., Yun, C.-O., Guise, T. A., et al. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.72 · Cited by 27
Targeted Radiotherapy of Bone Malignancies
Jansen, D. R., Krijger, G. C., Kolar, Z. I., Zonnenberg, B. A., & Zeevaart, J. R. (2010) · Current Drug Discovery Technologies · doi:10.2174/157016310793360675 · Cited by 25
Cella, D. F., Petrylak, D. P., Fishman, M., Teigland, C. M., Young, J. M., & Mulani, P. M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.058 · Cited by 22
Mitsiades, C. S., Sourla, A., Doillon, C. J., Lembessis, P., & Koutsilieris, M. (2000) · PubMed · Cited by 22
Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M. K., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3506 · Cited by 19
Rentsch, C. A., Cecchini, M. G., & Thalmann, G. N. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12284 · Cited by 12
New opportunities in the management of prostate cancer–related bone complications
Smith, M. R., Brown, G. A., & Fred Saad, C. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.08.004 · Cited by 7
Cited by
Islam, M. A., Xu, Y., Tao, W., Ubellacker, J. M., Lim, M., Aum, D., Lee, G. Y., Zhou, K., Zope, H., Yu, M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0284-0 · Cited by 339
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J., Xu, M., Yan, J., et al. (2014) · The FEBS Journal · doi:10.1111/febs.12902 · Cited by 299
Li, L., Karanika, S., Yang, G., Wang, J., Park, S., Broom, B. M., Manyam, G. C., Wu, W., Luo, Y., Basourakos, S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aam7479 · Cited by 295
Karantanos, T., Evans, C. P., Tombal, B., Thompson, T. C., Montironi, R., & Isaacs, W. B. (2015) · European Urology · doi:10.1016/j.eururo.2014.09.049 · Cited by 285
The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin
Pathak, R. K., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308899 · Cited by 255
Metadata
- Authors
- Sturge, J., Caley, M. P., & Waxman, J.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2011-05-10
- Volume
- 8
- Issue
- 6
- Pages
- 357-368
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2019008302
- Cited by
- 256
- References
- 126
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.